The North Karelia Central Hospital is a hospital located in the city of Joensuu in North Karelia, Finland. It was built in 1953, which makes it the oldest central hospital in the whole country.

During the past decade, North-Karelia Central Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "North-Karelia Central Hospital" #1 sponsor was "North Karelia Central Hospital" with 14 trials, followed by "Helsinki University Central Hospital" with 3 trials sponsored, "University of Helsinki" with 2 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Ipsen" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "North-Karelia Central Hospital" #1 collaborator was "Kuopio University Hospital" with 5 trials as a collaborator, "Tampere University Hospital" with 2 trials as a collaborator, "Turku University Hospital" with 2 trials as a collaborator, "Aarne Koskelo Foundation" with 1 trials as a collaborator and "Academy of Finland" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "North-Karelia Central Hospital" are "Abdominal Aortic Aneurysm" (3 trials), "Surgical Wound Infection" (3 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Aneurysm" (1 trials). Many other conditions were trialed in "North-Karelia Central Hospital" in a lesser frequency.

Most popular intervention types in "North-Karelia Central Hospital" are "Other" (8 trials), "Procedure" (7 trials), "Drug" (3 trials), "Device" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Conservative treatment" (2 trials), "ultrasound of aorta" (2 trials), "A highly hydrolyzed formula" (1 trials), "A regular cow's milk based formula" (1 trials) and "Botulinum toxin type A" (1 trials). Other intervention names were less common.

The vast majority of trials in "North-Karelia Central Hospital" are 19 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "North-Karelia Central Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in North-Karelia Central Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in North-Karelia Central Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".